Expert Perspectives in Idiopathic Pulmonary Fibrosis: Early Recognition, Appropriate Therapy Selection, and Proactive Patient Management
 
Release Date: June 30, 2017
Last Reviewed: May 31, 2017
Expiration Date: June 30, 2018
Time to Complete Activity:  2.0 hours
 
This activity is provided by Global Education Group.  Paradigm Medical Communications, LLC, is the educational partner.
                                                        
                                             
Faculty
Joao A. de Andrade, MD (Co-Chair)
Professor of Medicine
Director, Pulmonary and Critical Care Fellowship Program
Director, Interstitial Lung Disease Program
Division of Pulmonary, Allergy & Critical Care Medicine
University of Alabama at Birmingham, School of Medicine
Birmingham, AL
 
David J. Lederer, MD, MS (Co-Chair)
Associate Professor
Pulmonary Director, Pulmonary & Intensive Care Translational Outcomes Research (PICTOR) Group
Co-Director, Interstitial Lung Disease Program
Columbia University Medical Center
New York, NY
 
D. Ralph Crowe, MD
Professor
Department of Pathology
University of Alabama at Birmingham, School of Medicine
Birmingham, AL
 
Lanier L. O’Hare, MSN, CRNP
Nurse Practitioner
Sarcoidosis, ILD and Pulmonary Access Clinics
University of Alabama at Birmingham, School of Medicine
Birmingham, AL
 
Sushilkumar K. Sonavane, MBBS, DMRD
Program Director, Cardiopulmonary Fellowship
Associate Professor, Cardiopulmonary Section
University of Alabama at Birmingham, School of Medicine
Birmingham, AL
 
Hary Suseelan, MD, FCCP
Division of Pulmonary, Critical Care and Sleep Medicine
Health Quest Medical Practice
Medical Director
Respiratory Care Services
Vassar Brothers Medical Center
Poughkeepsie, NY
 
Target Audience
This activity has been designed to address the educational needs of pulmonologists, including: academic, community-based, and those at interstitial lung disease (ILD) centers. It will also benefit other healthcare professionals who may contribute to the multidisciplinary ILD team, such as radiologists, pathologists, rheumatologists, gastroenterologists, nurse practitioners, PAs, and critical care medicine specialists, as well as primary care clinicians and other health professionals interested in the diagnosis and management of patients with idiopathic pulmonary fibrosis (IPF).  
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Outline signs and symptoms of idiopathic pulmonary fibrosis, as well as recommended testing for its timely diagnosis.
  • Review current guidelines and recent clinical trial data for idiopathic pulmonary fibrosis therapy.
  • Assess strategies for addressing patient comorbidities in light of their impact on idiopathic pulmonary fibrosis treatment.
     
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation Statement
Global Education Group designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2.0 Category 1 credits for completing this activity.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.  Individuals are responsible for checking with the AANPCP for further guidelines.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or inquire@globaleducationgroup.com.
 
Disclosure of Commercial Support
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc. 
 
Instructions for Participation
To receive a CME certificate of participation, participants must:
  • Follow instructions to register or log in with your professional information and complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
 
There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 video and audio.
 
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues, please email us at contactus@paradigmmc.com.

Disclosure and Resolution of Conflict of Interest
Global Education Group (Global) and Paradigm Medical Communications, LLC (Paradigm) require instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.  All identified conflicts of interest are thoroughly vetted by Global and Paradigm for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. 
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Name of Faculty or Presenter
Reported Financial Relationship
Joao A. de Andrade, MD
Retained Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,  Genentech, Inc. 
David J. Lederer, MD, MS
Retained Consultant: FibroGen, Inc., Global Blood Therapeutics Inc., Philips Respironics, Roche/Genentech, Inc., Sanofi Genzyme, Veracyte
D. Ralph Crowe, MD
No relevant financial relationships to disclose.
Lanier L. O’Hare, MSN, CRNP
No relevant financial relationships to disclose.
Sushilkumar K. Sonavane, MBBS, DMRD
No relevant financial relationships to disclose.
Hary Suseelan, MD, FCCP
No relevant financial relationships to disclose.
 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Name of Planner or Manager
Reported Financial Relationship
Lindsay Brovansky
No financial relationships to disclose
Jamie Patrick
No financial relationships to disclose
 
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Paradigm do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Global Education Group or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global or Paradigm. Global and Paradigm accept no liability for the content referenced in this activity.
 
Privacy policy
Global and Paradigm are committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Global and Paradigm to continuously improve the learning experience.
 
Global Education Group and Paradigm Medical Communications, LLC, do not transfer, sell, or share personal information with outside parties. Global Education Group and Paradigm will not otherwise disclose personal information unless required to in a legal process. Global and Paradigm staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.